Fortress Biotech (FBIO) Current Leases (2019 - 2026)

Fortress Biotech's Current Leases history runs 7 years deep, the most recent figure standing at $2.1 million for Q4 2025.

• In Q4 2025, Current Leases fell 18.91% year-over-year to $2.1 million; the TTM figure through Dec 2025 stood at $2.1 million (down 18.91% YoY), while the FY2025 annual figure was $2.1 million, down 18.91% from the prior year.
• Current Leases for Q4 2025 stood at $2.1 million, roughly flat from $2.1 million in the prior quarter.
• The five-year high for Current Leases was $2.6 million in Q4 2024, with the low at $1.8 million in Q1 2021.
• The 5-year median for Current Leases is $2.2 million (2022), against an average of $2.3 million.
• The sharpest annual moves came in 2021 and 2025: Current Leases grew 20.62% in 2021, then declined 18.91% in 2025.
• Fortress Biotech's Current Leases stood at $2.1 million in 2021, then advanced by 16.3% to $2.4 million in 2022, then climbed by 3.11% to $2.5 million in 2023, then grew by 3.96% to $2.6 million in 2024, then slipped by 18.91% to $2.1 million in 2025.
• Business Quant data shows FBIO's Current Leases at $2.1 million in Q4 2025, $2.1 million in Q3 2025, and $2.1 million in Q2 2025.